Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention

Trial Profile

Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 25 Apr 2017

At a glance

  • Drugs Ticagrelor (Primary) ; Aspirin
  • Indications Acute coronary syndromes; Coronary artery disease; Myocardial infarction
  • Focus Adverse reactions
  • Acronyms TWILIGHT
  • Most Recent Events

    • 27 Jan 2017 Planned End Date changed from 1 Oct 2017 to 1 May 2019.
    • 27 Jan 2017 Planned primary completion date changed from 1 Oct 2017 to 1 May 2019.
    • 01 Dec 2016 Results published in the American Heart Journal
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top